Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS) (Q33757516)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 27, 2010

Language	Label	Description	Also known as
English	Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)	scientific article published on November 27, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS) (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

A. Fahrleitner-Pammer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

B. L. Langdahl

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

F. Marin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

F. Jakob

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

D. Karras

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

A. Barrett

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

Ö. Ljunggren

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

J. B. Walsh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

G. Rajzbaum

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

C. Barker

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

W. F. Lems

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

language of work or name

0 references

publication date

27 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

full work available at URL

https://link.springer.com/content/pdf/10.1007/s00198-010-1498-5.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

https://europepmc.org/articles/PMC3169763

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

https://europepmc.org/articles/PMC3169763?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21113576

4 September 2024

http://www.springerlink.com/index/pdf/10.1007/s00198-010-1498-5

1 reference

10.1007/S00198-010-1498-5

https://api.crossref.org/works/10.1007/S00198-010-1498-5

4 September 2024

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2709-2719

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

A randomized trial of vertebroplasty for osteoporotic spinal fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

From randomized controlled trials to observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Back pain in osteoporotic vertebral fractures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Reduced risk of back pain following teriparatide treatment: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Study subjects and ordinary patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

The clinical impact of vertebral fractures: quality of life in women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

21 June 2018

Health-related quality of life and radiographic vertebral fracture.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Clinical consequences of vertebral fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis?

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

30 October 2018

Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169763

30 October 2018

Risk of Mortality Following Clinical Fractures

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1498-5

21 January 2018

Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21113576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies with different types of visual analog scales for measurement of pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21113576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21113576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/21113576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Journal of Rheumatology

7

34

1551

author name string

F Salaffi

publication date

2007

1 reference

10.1007/S00198-010-1498-5

https://api.crossref.org/works/10.1007/S00198-010-1498-5

4 September 2024

The Journal of Rheumatology

9

32

2405

author name string

SL Silverman

publication date

2005

1 reference

10.1007/S00198-010-1498-5

https://api.crossref.org/works/10.1007/S00198-010-1498-5

4 September 2024

The Journal of Rheumatology

31

32

1556

author name string

PD Miller

publication date

2005

1 reference

10.1007/S00198-010-1498-5

https://api.crossref.org/works/10.1007/S00198-010-1498-5

4 September 2024

Identifiers

10.1007/S00198-010-1498-5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33757516&oldid=2243286800"